Company Filing History:
1 out of 67 
1 out of 57 Years Active: 2006-2017
Title: Brahim Zadi: Innovator in Liposome Technology
Introduction
Brahim Zadi is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of liposome formulations. With a total of 2 patents, his work has the potential to impact drug delivery systems significantly.
Latest Patents
Brahim Zadi's latest patents include innovative methods for forming liposomes. One patent describes a method of forming liposomes where compositions of reagents are created by forming empty liposomes, mixing them with a sugar solution and a reagent, and then drying the mixture. This process results in small liposomes with high entrapment efficiency, which is particularly useful in pharmaceutical production. Another patent focuses on producing liposomes containing lipophilic active ingredients. This method involves dehydrating a mixture of liposomes, a lipophilic active ingredient, and sugar, followed by a rehydration step to create dehydration-rehydration vesicles. The lipophilic drug mentioned is paclitaxel, and the sugar used is typically sucrose. The formulation includes liposome-forming compounds such as cholesterol and phosphatidylcholine, with a preferred sugar-to-lipid ratio of at least 5:1 w/w.
Career Highlights
Throughout his career, Brahim Zadi has worked with prominent organizations, including the Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom and Lipoxen Technologies Incorporated. His experience in these roles has contributed to his expertise in liposome technology and pharmaceutical applications.
Collaborations
Brahim Zadi has collaborated with notable individuals in his field, including Gregory Gregoriadis and Pramukh N Jayasekera. These collaborations have likely enriched his research and development efforts in liposome technology.
Conclusion
Brahim Zadi is a distinguished inventor whose work in liposome technology has the potential to advance pharmaceutical formulations significantly. His innovative methods and collaborations highlight his contributions to the field.